Company Fact Sheet

CSL Behring, a member of the CSL Group of companies, is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies to treat people in more than 100 countries with serious and life-threatening medical conditions.

We collaborate with patient and biomedical communities to improve access to therapies, advance scientific knowledge and support future medical research.

Our world-class commercial operation, combined with a large and focused R&D team and operational excellence, enable us to accurately identify, successfully develop and dependably deliver innovations that patients and providers want.

CSL has 1,700 dedicated scientists who focus on solving patients’ unmet needs. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. The parent company, CSL Limited (AXS:CSL; USOTC:CSLLY), is headquartered in , .

INNOVATION EMPLOYEES CSL Behring’s commitment to innovation is reflected in 25,000+ CSL employees worldwide breakthrough therapies currently in development to reduce the OPERATIONAL HEADQUARTERS risk of early recurrent cardiovascular events, improve outcomes in King of Prussia, Pennsylvania, USA organ transplant, and treat sickle cell disease, β-thalassemia and autoimmune diseases. PLASMA COLLECTION 300+ collection centers globally THERAPEUTIC AREAS • • Cardiovascular and Metabolic MANUFACTURING Bern, Switzerland; Marburg, Germany; • Hematology • Transplant Broadmeadows, Australia; Kankakee, • Respiratory Illinois, USA; Wuhan, China

For more information, visit CSLBehring.com. CSL BEHRING 2021 FULL YEAR PERFORMANCE For inspiring stories about the Therapeutic Group ROW promise of , visit Vita 44% 6% Therapy Sales Change1 at CSLBehring.com/Vita. $m % Asia Pac 18% Immunoglobulins 4,238 3% FOLLOW US ON Global Sales North 1,071 61% America US $8.6B 49% 5% twitter.com/CSLBehring(@CSLBehring) Hemophilia 1,107 (4%) 6% linkedin.com/company/CSL-Behring Specialty 1,770 2% EU 27% facebook.com/CSL-Behring-51976781570 Other2 388 (7%) 6% instagram.com/CSLBehring Total 8,574 6% youtube.com/user/CSLBehringGlobal

1. Growth percentages shown at constant currency to remove the impact of exchange rate movements, facilitating comparability of operational performance. See end note for further detail. 2. Includes HPV royalties & Hyperimmunes

Biotherapies for Life™ is a registered trademark of CSL Behring LLC in various jurisdictions. Driven by Our Promise™ CSL Behring is a member of the CSL Group of companies. August 2021.